Raymond James & Associates increased its holdings in UFP Technologies, Inc. (NASDAQ:UFPT – Free Report) by 11.3% in the third quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 18,602 shares of the industrial products company’s stock after acquiring an additional 1,887 shares during the quarter. Raymond James & Associates owned about 0.24% of UFP Technologies worth $5,891,000 as of its most recent filing with the Securities & Exchange Commission.
Several other large investors have also added to or reduced their stakes in the stock. Creative Planning bought a new stake in UFP Technologies in the third quarter worth $231,000. Annex Advisory Services LLC grew its position in shares of UFP Technologies by 4.9% during the 3rd quarter. Annex Advisory Services LLC now owns 45,868 shares of the industrial products company’s stock valued at $14,526,000 after acquiring an additional 2,142 shares during the period. Contravisory Investment Management Inc. bought a new stake in shares of UFP Technologies during the 3rd quarter valued at $224,000. Mountain Pacific Investment Advisers LLC grew its position in shares of UFP Technologies by 0.3% during the third quarter. Mountain Pacific Investment Advisers LLC now owns 92,976 shares of the industrial products company’s stock worth $29,445,000 after purchasing an additional 238 shares in the last quarter. Finally, Fulton Bank N.A. purchased a new position in UFP Technologies during the third quarter valued at $222,000. Institutional investors own 87.28% of the company’s stock.
Insider Buying and Selling
In other news, CEO R Jeffrey Bailly sold 10,887 shares of UFP Technologies stock in a transaction that occurred on Thursday, August 8th. The shares were sold at an average price of $310.46, for a total transaction of $3,379,978.02. Following the sale, the chief executive officer now owns 143,970 shares of the company’s stock, valued at approximately $44,696,926.20. The trade was a 0.00 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. In other news, CFO Ronald J. Lataille sold 4,798 shares of the firm’s stock in a transaction dated Wednesday, August 21st. The stock was sold at an average price of $330.44, for a total transaction of $1,585,451.12. Following the sale, the chief financial officer now owns 41,332 shares of the company’s stock, valued at approximately $13,657,746.08. This trade represents a 0.00 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, CEO R Jeffrey Bailly sold 10,887 shares of the business’s stock in a transaction that occurred on Thursday, August 8th. The stock was sold at an average price of $310.46, for a total value of $3,379,978.02. Following the sale, the chief executive officer now owns 143,970 shares of the company’s stock, valued at approximately $44,696,926.20. The trade was a 0.00 % decrease in their position. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 66,536 shares of company stock worth $20,983,894. 6.17% of the stock is owned by corporate insiders.
UFP Technologies Trading Down 2.6 %
UFP Technologies (NASDAQ:UFPT – Get Free Report) last posted its quarterly earnings data on Wednesday, July 31st. The industrial products company reported $1.86 EPS for the quarter. UFP Technologies had a return on equity of 17.53% and a net margin of 11.87%. The firm had revenue of $110.18 million during the quarter.
Wall Street Analysts Forecast Growth
Separately, Lake Street Capital raised their target price on shares of UFP Technologies from $344.00 to $392.00 and gave the stock a “buy” rating in a report on Wednesday, July 17th.
Get Our Latest Analysis on UFPT
UFP Technologies Company Profile
UFP Technologies, Inc designs and manufactures solutions for medical devices, sterile packaging, and other highly engineered custom products. The company offers protective drapes for robotic surgery, single patient use surfaces, advanced wound care, infection prevention, disposables for surgical and endoscopic procedures, packaging for medical devices, orthopedic implants, biopharma drug manufacturing, and coils for catheters; and molded components for applications in acoustic insulation, interior trim, load floors, sunshades, SUV cargo cover handles, driveshaft damping, engine and manifold covers, quarter panels, and wheel liners.
Featured Stories
- Five stocks we like better than UFP Technologies
- What Are Dividend Achievers? An Introduction
- Microsoft Can Hit New All-Time Highs This Year – Here’s Why
- Technology Stocks Explained: Here’s What to Know About Tech
- Zillow Stock’s Bull Case: Why This Recent Sell-Off Could Be a Buy
- 2 Fintech Stocks to Buy Now and 1 to Avoid
- IonQ’s Quantum Surge: Ride the Wave or Cash Out?
Want to see what other hedge funds are holding UFPT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UFP Technologies, Inc. (NASDAQ:UFPT – Free Report).
Receive News & Ratings for UFP Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UFP Technologies and related companies with MarketBeat.com's FREE daily email newsletter.